Sweden’s RhoVac Aims To Become An M&A Target

Late 2021 RV001 Phase IIb Data May Offer Trigger, CEO Says

 
• By Sten Stovall
  
Diagnosis
RhoVac's RV001 targets the RhoC protein which is indispensable for metastasis • Source: Shutterstock

More from Clinical Trials

More from R&D